NAUT · Company research
Nautilus Biotechnolgy, Inc. Common Stock (NAUT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableOther
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1.96 | $141,120,669.18 | 127954669.18 | — | — | — | 742.7403641052631579 | 1.07633678976752699982 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.